Increasing resistance to standard prophylactic antibiotics poses a serious and growing danger for patients undergoing immunosuppressing cancer chemotherapies.
There was no significant difference for survival and an increased risk for relapse with iHDI in patients with stage 3 melanoma.
Skin Cancer News
Financial stress of cancer care as well as factors that make certain populations more susceptible to certain types of cancers were key points.
More Skin Cancer Information
This fact sheet offers tips to decrease the risk of malignant melanoma, the fastest growing forms of skin cancer.
This patient fact sheet describes risk factors and preventative measures in skin cancer, malignant melanoma.
This fact sheet helps cancer patients learn what they can do to protect themselves from skin cancer.
Sign Up for Free e-newsletters
Cancer Therapy Advisor Articles
- Prognostic Score Proposed for Patients With Advanced Melanoma Treated With Ipilimumab
- Patients With Colorectal Cancer Experience Substantial Cognitive Impairment
- Low-dose Estradiol Effective in Certain Patients With Advanced Breast Cancer
- Head and Neck Cancer Patients Have Higher Suicide Risk
- Enzalutamide Effective, Well Tolerated in Elderly Patients With Prostate Cancer
- Consuming Meat Cooked at High Temperature May Raise RCC Risk
- The High Costs of Cancer Treatments Lead to Calls for Reform
- Breast Cancer Question-and-Answer Session With Charles Vogel, MD
- Nearly 10% of Patients Develop Breast Cancer After Prior Benign Breast Disease
- FCR Achieves Long-term Disease-free Survival in IGHV-mutated CLL
- FDA Approves Necitumumab for Metastatic Squamous NSCLC
- Financial Toxicity Among Topics Presented at AACR Conference
- Genomic Testing More Likely to Impact Younger Women
- Low BMI Linked With Progression, Death Risk in Colorectal Cancer
- Alectinib Highly Active, Safe in Advanced Crizotinib-refractory ALK+ NSCLC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|